Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine is ineffective for treating frontal fibrosing alopecia with lupus erythematosus.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

Porcine PRP can replace FBS and may promote hair growth.

Lichen planopilaris can be triggered by prolonged scalp traction and can be treated with corticosteroids.

Dermoscopes help tell FPHL apart from other hair loss types and can detect it early by identifying specific patterns.

Patients with lichen planopilaris/frontal fibrosing alopecia have a higher rate of vitamin D deficiency than the general US population.

Female pattern hair loss affects many women and requires specialized care.

A protein called PLC2 is important for the growth and development of plant roots influenced by auxin.

Platelet-rich fibrin shows promise for treating oral lesions but needs more research.

The study found a link between the severity of Lichen Planopilaris seen by doctors and the details seen under a microscope, and created a new way to measure this severity.

Long-lived proteins may predict age-related diseases.

Microbial-derived polydeoxyribonucleotide is a better and more sustainable alternative to salmon-based versions for healing and immune support.

Platelet-rich plasma therapy effectively treated laser-induced skin lightening.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

LncRNA RP11-818024.3 helps hair growth and recovery in hair loss by boosting cell survival and reducing cell death.

Sunscreen spray on the scalp may be linked to a type of scarring hair loss.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

PRF and CGF are becoming more popular than PRP in regenerative medicine due to their simplicity and lack of additives.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Placenta extract may protect and improve liver health by reducing stress, inflammation, and cell death, and promoting regeneration.

Women with lichen planopilaris and frontal fibrosing alopecia often have other health issues like hypothyroidism and lupus.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.